dimanche 15 novembre 2026
RechercherExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
Source document· November 20, 2025

Netflix (NFLX) Down 1.5% Since Last Earnings Report: Can It Rebound?

View original at finance.yahoo.com
Netflix (NFLX) Down 1.5% Since Last Earnings Report: Can It Rebound? It has been about a month since the last earnings report for Netflix (NFLX)…
Opening lines of the source · short snapshot: read the full document at the original

Ce que nous avons tiré de cette source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Netflix is on track to more than double ad revenues in 2025, albeit from a relatively small base

    80% confidence
  • Netflix achieved its highest quarterly viewing share ever in both the United States and the United Kingdom in Q3 2025

    80% confidence
  • The earnings shortfall was primarily attributed to a one-time $619 million expense related to an ongoing dispute with Brazilian tax authorities

    80% confidence
  • Netflix does not expect the Brazilian tax matter to have a material impact on future results

    80% confidence
  • Absent the Brazilian tax expense, Netflix would have exceeded its third-quarter operating margin forecast

    80% confidence
  • Netflix has a Zacks Rank #4 (Sell) and analysts expect a below average return from the stock in the next few months

    80% confidence
  • In the fourth quarter, Netflix is using AI to test new ad formats to generate the most relevant ad creative and placement for members, and for faster development of media plans

    80% confidence
  • Total viewing hours grew faster in the third quarter than in the first half of 2025

    80% confidence
  • These AI advancements will enable Netflix to test, iterate, and innovate on dozens of ad formats by 2026

    80% confidence
Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Notre lecture des données ›
Signaux que nous suivons
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Tendances que nous surveillons ›
Là où les sources divergent
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Nous signalons les conflits ouvertement ›
Vérifié récemment
✓ Vérifié avec la source d'origine
4,997
faits reliés à leur source, et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,997 faits vérifiés avec la source5,585 documents sources archivés
Interrogez ces données → isubstrate.com
Netflix (NFLX) Down 1.5% Since Last Earnings Report: Can It Rebound?: Source | Via News | fr.via.news